Begin main content

Patient Input ― An Integral Part of the 2018 CADTH Symposium

January 16, 2018
Given the theme of the 2018 CADTH Symposium ― Managing Health Technologies: Supporting Appropriate, Affordable, and Accessible Care ― which relates so directly to patients, CADTH is very pleased that our conference is once again officially accredited by Patients Included. The annual CADTH Symposium is a must-attend health policy event that bring...

New at CADTH — January 2018

January 11, 2018
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.

Call for Patient Input: Duodopa

January 11, 2018
CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website. Duodopa Brand name Generic name Manufacturer ...

Call for Patient Input: Dysport Therapeutic

January 3, 2018
CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website. Dysport Therapeutic Brand name Generic name Ma...

One Year Later — CADTH’s Commitment to the Opioid Crisis

December 18, 2017
A Statement from Dr. Brian O’Rourke, President and CEO In November 2016 I represented CADTH at the two-day Opioid Summit, joining many others to discuss Canada’s response to the escalating opioid crisis and make a formal commitment to the Joint Statement of Action to Address the Opioid Crisis. I won’t soon forget the people I met and the stories...